Concepedia

Esther Zamora

EZ

11

Publications

1.1K

Citations

11

H-Index

2012

Active since

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Vall d'Hebron Institute of Oncology

Institut Català d'Oncologia

Hebron University

Institut d'Investigació Biomédica de Bellvitge

Esther Zamora is an author at Vall d'Hebron Hospital Universitari specializing in medicine, pathology, and cancer research.

ORCID

Top concepts

Publications per year

2012–2024

11

Publications

11

MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Maura N. Dickler, Sara M. Tolaney, Hope S. Rugo et al. · Clinical Cancer Research · 2017 · 669 citations · Full text

Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer

S. Cedrés, Davis Y. Torrejon, A. Martínez et al. · Clinical & Translational Oncology · 2012 · 300 citations

, , +7

18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial

Miguel Quintela-Fandiño, Aňa Lluch, Luís Manso et al. · Clinical Cancer Research · 2016 · 36 citations

Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors

Noémie Travier, Genevieve Buckland, Joan Vendrell et al. · European Journal of Cancer Care · 2018 · 31 citations

Expression of Wilms’ tumor gene (WT1) is associated with survival in malignant pleural mesothelioma

S. Cedrés, M. A. Montero, Esther Zamora et al. · Clinical & Translational Oncology · 2013 · 19 citations

, , +8

Rows per page

1–5 of 11